Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "Quality"

2787 News Found

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
Healthcare | April 07, 2026

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave

As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact


SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
Healthcare | April 06, 2026

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education

Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings


Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access
Hospitals | April 06, 2026

Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access

New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients


Healthcare major QCIL signs solar power pacts with AMPIN and Radiance
Sustainability | April 06, 2026

Healthcare major QCIL signs solar power pacts with AMPIN and Radiance

Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network


SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail
Hospitals | April 05, 2026

SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail

The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options


BASF Pharma Solutions announces up to 20% price hike on excipients and APIs
News | April 04, 2026

BASF Pharma Solutions announces up to 20% price hike on excipients and APIs

The company said the increase—up to 20%—takes effect immediately, or as current contracts allow


Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
Drug Approval | April 04, 2026

Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib

ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA


PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports
News | April 04, 2026

PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports

Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26


ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
News | April 03, 2026

ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses

Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology


Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra
Hospitals | April 03, 2026

Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra

Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure